Einträge von Ditsch, N. auf dem Publikationsserver

Kast, K., Rhiem, K., Wappenschmidt, B., Hahnen, E., Hauke, J., Bluemcke, B., Zarghooni, V., Herold, N., Ditsch, N., Kiechle, M., Braun, M., Fischer, C., Dikow, N., Schott, S. , Rahner, N., Niederacher, D., Fehm, T., Gehrig, A., Mueller-Reible, C., Arnold, N. , Maass, N., Borck, G., de Gregorio, N., Scholz, C., Auber, B., Varon-Manteeva, R., Speiser, D., Horvath, J., Lichey, N., Wimberger, P., Stark, S., Faust, U., Weber, Bernhard H. F. , Emons, G., Zachariae, S., Meindl, A., Schmutzler, R. K., Engel, C. und German Consortium for Hereditary Breast and Ovarian Cancer, . (2016) Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer. Journal of Medical Genetics 53 (7), S. 465-471. Volltext nicht vorhanden.

Tchatchou, S., Riedel, A., Lyer, S., Schmutzhard, J., Strobel-Freidekind, O., Gronert-Sum, S., Mietag, C., D'Amato, M. , Schlehe, B., Hemminki, K., Sutter, C., Ditsch, N., Blackburn, A. , Hill, L. Z., Jerry, D. J., Bugert, P., Weber, Bernhard H. F. , et, al., make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference , make_name_string expected hash reference, make_name_string expected hash reference, make_name_string expected hash reference und make_name_string expected hash reference (2010) Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity. Human Mutation 31 (1), S. 60-66. Volltext nicht vorhanden.

Tchatchou, S., Jung, A., Hemminki, K., Sutter, C., Wappenschmidt, B., Bugert, P., Weber, Bernhard H. F. , Niederacher, D., Arnold, N. , Varon-Mateeva, R., Ditsch, N., Meindl, A., Schmutzler, R. K., Bartram, C. R. und Burwinkel, B. (2009) A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 30 (1), S. 59-64. Volltext nicht vorhanden.

Osorio, A. , Milne, R. L., Pita, G., Peterlongo, P. , Heikkinen, T. , Simard, J., Chenevix-Trench, G., Spurdle, A. B. , Beesley, J. , Chen, X., Healey, S., Neuhausen, S. L., Ding, Y. C., Couch, F. J., Wang, X., Lindor, N., Manoukian, S., Barile, M., Viel, A. , Tizzoni, L., Szabo, C. I., Foretova, L., Zikan, M. , Claes, K. , Greene, M. H., Mai, P., Rennert, G., Lejbkowicz, F., Barnett-Griness, O., Andrulis, I. L., Ozcelik, H., Weerasooriya, N., Gerdes, A.-M. , Thomassen, M., Cruger, D. G., Caligo, M. A. , Friedman, E., Kaufman, B., Laitman, Y., Cohen, S., Kontorovich, T., Gershoni-Baruch, R., Dagan, E., Jernström, H., Askmalm, M. S., Arver, B., Malmer, B., Domchek, S. M., Nathanson, K. L. , Brunet, J. , Ramón y Cajal, T., Yannoukakos, D. , Hamann, U., Hogervorst, F. B. L., Verhoef, S., García, E.B. Gómez, Wijnen, J. T., van den Ouweland, A., Easton, D. F., Peock, S., Cook, M., Oliver, C. T., Frost, D., Luccarini, C., Evans, D. G. , Lalloo, F., Eeles, R. , Pichert, G., Cook, J., Hodgson, S., Morrison, P. J., Douglas, F., Godwin, A. K., Sinilnikova, O. M., Barjhoux, L., Stoppa-Lyonnet, D., Moncoutier, V., Giraud, S., Cassini, C., Olivier-Faivre, L., Révillion, F., Peyrat, J.-P., Muller, D., Fricker, J.-P., Lynch, H. T., John, E. M., Buys, S. M., Daly, M., Hopper, J. L., Terry, M. B., Miron, A., Yassin, Y., Goldgar, D., Singer, C. F., Gschwantler-Kaulich, D., Pfeiler, G., Spiess, A.-C., Hansen, Thomas v. O., Johannsson, O. T., Kirchhoff, T. , Offit, K., Kosarin, K., Piedmonte, M., Rodriguez, G. C., Wakeley, K., Boggess, J. F., Basil, J., Schwartz, P. E., Blank, S. V., Toland, A. E., Montagna, M., Casella, C., Imyanitov, E. N., Allavena, A., Schmutzler, R. K., Versmold, B., Engel, C. , Meindl, A., Ditsch, N., Arnold, N. , Niederacher, D., Deißler, H., Fiebig, B., Varon-Mateeva, R., Schaefer, D., Froster, U. G., Caldes, T., de la Hoya, M., McGuffog, L., Antoniou, A. C., Nevanlinna, H. , Radice, P. und Benítez, J. (2009) Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA). British Journal of Cancer 101 (12), S. 2048-2054. Volltext nicht vorhanden.

Hartmaier, R. J. , Tchatchou, S., Richter, A. S., Wang, J., McGuire, S. E., Skaar, T. C., Rae, J. M., Hemminki, K., Sutter, C., Ditsch, N., Bugert, P., Weber, Bernhard H. F. , Niederacher, D., Arnold, N. , Varon-Mateeva, R., Wappenschmidt, B., Schmutzler, R. K., Meindl, A., Bartram, C. R., Burwinkel, B. und Oesterreich, S. (2009) Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. BMC Cancer 9, S. 438. Volltext nicht vorhanden.

Yang, R., Chen, B., Hemminki, K., Wappenschmidt, B., Engel, C. , Sutter, C., Ditsch, N., Weber, Bernhard H. F. , Niederacher, D., Arnold, N. , Meindl, A., Bartram, C., Schmutzler, R. und Burwinkel, B. (2009) Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk. Breast Cancer Research and Treatment 118 (2), S. 407-413. Volltext nicht vorhanden.